brainscienceblogs.com
VOLUME 42, NUMBER 2, 2009 & VOLUME 42, NUMBER 3, 2009
RECENTLY PUBLISHED:
Assessing Rates and Predictors of Tachyphylaxis During the Prevention of Recurrent Episodes of Depression With Venlafaxine ER for Two Years (PREVENT) Study
Anthony J. Rothschild, Boadie W. Dunlop, David L. Dunner, Edward S. Friedman, Alan J. Gelenberg, Peter Holland, James H. Kocsis, Susan G. Kornstein, Richard Shelton, Madhukar H. Trivedi, John M. Zajecka, Corey Goldstein, Michael E. Thase, Ron Pedersen, Martin B. Keller
Analysis of Depressive Symptoms in Patients With Major Depressive Disorder Treated With Desvenlafaxine or Placebo
Susan G. Kornstein, Maurizio Fava, Qin Jiang, Karen A. Tourian Drug Disposition & Pharmacokinetics
Efficacy of Omega 3 Fatty Acids in Mood Disorders: A Systematic Review and Metaanalysis
Nina V. Kraguljac, Victor M. Montori, Mani Pavuluri, High S. Chai, Brian S. Wilson, Sencan S. Unal General Psychiatry
A Systematic Review of Augmentation Strategies for Patients with Major Depressive Disorder
Rachael Fleurence, Quynh-Van Tran, Rebecca Williamson, Yonghua Jing, Edward Kim, Quynh-Van Tran, Andrei Pikalov, Michael E. Thase Complicated Case Histories
Neonatal Outcomes with the Use of Lamotrigine for Bipolar Disorder in Pregnancy and Breastfeeding: A Case Series and Review of the Literature
Laura Wakil, C. Neill Epperson, Juan Gonzalez, John P. O’Reardon, Deborah R. Kim
Switching to Duloxetine Remits Ziprasidone – Associated Urinary Incontinence and Improves Neuropsychiatric Behavior in Dementia: Possible Relationship of Incontinence to 5HT2 Receptor Blockade
Edward C. Lauterbach, Florence T. Baralatei
Clinical Significance of Transcranial Magnetic Stimulation (TMS) in the Treatment of Pharmacoresistant Depression: Synthesis of Recent Data
Mark A. Demitrack, MD, Michael E. Thase, MD
Aram Oganesian, PhD, Adam D. Shilling, PhD, Ruth Young-Sciame, BS, Judy Tran, BS, Adiba Watanyar, BS, Farooq Azam, MS, John Kao, Louis Leung, PhD
Revisiting the Effectiveness of Standard Antidepressants in
Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?
Alan G. Mallinger, MD, Ellen Frank, PhD, Michael E. Thase, MD
Michelle M. Barwell, MD, Nancy DiazGranados, MD, David A. Luckenbaugh, MA, David J. Kupfer, MD
Statistical Strategies for Randomized Controlled Clinical Trials to Detect Differential Onset of Action
Andrew C. Leon, PhD
Recent-Onset Schizophrenia and Adolescent Cannabis Use: MRI Evidence for Structural Hyperconnectivity?
Bart D. Peters, MD, Lieuwe de Haan, MD, PhD, Erik-Jan Vlieger, MD, PhD, Charles B. Majoie, MD, PhD, Gerard J. den Heeten, MD, PhD, Don H. Linszen MD, PhD